226 related articles for article (PubMed ID: 25665470)
1. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
Haluskova J; Lachvac L; Nagy V
Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
[TBL] [Abstract][Full Text] [Related]
2. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer.
Zhang W; Jiao H; Zhang X; Zhao R; Wang F; He W; Zong H; Fan Q; Wang L
Mol Med Rep; 2015 Jul; 12(1):141-6. PubMed ID: 25738352
[TBL] [Abstract][Full Text] [Related]
4. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
[TBL] [Abstract][Full Text] [Related]
6. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of DNA methylation in multifocal prostate cancer.
Serenaite I; Daniunaite K; Jankevicius F; Laurinavicius A; Petroska D; Lazutka JR; Jarmalaite S
Virchows Arch; 2015 Jan; 466(1):53-9. PubMed ID: 25369892
[TBL] [Abstract][Full Text] [Related]
9. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
Rogers CG; Gonzalgo ML; Yan G; Bastian PJ; Chan DY; Nelson WG; Pavlovich CP
J Urol; 2006 Nov; 176(5):2280-4. PubMed ID: 17070312
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
[TBL] [Abstract][Full Text] [Related]
12. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
[TBL] [Abstract][Full Text] [Related]
14. [GSTP1, APC and RASSF1 gene methylation in prostate cancer samples: comparative analysis of MS-HRM method and Infinium HumanMethylation450 BeadChip beadchiparray diagnostic value].
Skorodumova LO; Babalyan KA; Sultanov R; Vasiliev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Generozov EV; Larin AK; Kostryukova ES; Sharova EI
Biomed Khim; 2016 Nov; 62(6):708-714. PubMed ID: 28026816
[TBL] [Abstract][Full Text] [Related]
15. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
[TBL] [Abstract][Full Text] [Related]
16. Molecular and Clinicopathological Aspects of Prostate Cancer in Bulgarian Probands.
Tsvetkova A; Todorova A; Todorov T; Georgiev G; Drandarska I; Mitev V
Pathol Oncol Res; 2015 Sep; 21(4):969-76. PubMed ID: 25753984
[TBL] [Abstract][Full Text] [Related]
17. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
19. DNA-based detection of prostate cancer in blood, urine, and ejaculates.
Goessl C; Müller M; Heicappell R; Krause H; Miller K
Ann N Y Acad Sci; 2001 Sep; 945():51-8. PubMed ID: 11708494
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
